Zentalis Pharmaceuticals, Inc. (ZNTL) Insider Trading

Name: Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 1, 2026): Ingmar Bruns (Chief Medical Officer): Grant/Award of 9,727 shares, $21.2K.

Get alerted when insiders trade ZNTL

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta